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Abstract
Background Although angiogenesis is an obvious pathological manifestation in the pathogenesis of syphilis, little is
known about the underlying mechanisms of angiogenesis induced by reactions to Treponema pallidum antigens.
Objective In this study, we sought to determine the role of recombinant T. pallidum Tp47 in promoting angiogenesis in
endothelial cells and the related mechanism.
Methods Evaluation of the pro-angiogenic activity of recombinant T. pallidum Tp47 in human umbilical vein endothelial
cells (HUVECs) was assessed, and the balance of matrix metalloproteinase (MMP)/tissue inhibitor of metalloproteinase
(TIMP) and the mechanisms underlying the involvement of Akt/mTOR/S6 pathways in this process were explored.
Results Under stimulation by Tp47, HUVECs exhibited obvious proliferation, migration and tube formation. In addition,
the apparent promotion of angiogenesis by Tp47 was observed using a zebrafish embryo model. During angiogenesis,
the levels of MMP-1 and MMP-10 were significantly elevated, whereas those of TIMP-1 and TIMP-2 did not change. In
addition, after transfection with siRNAMMP-1 and siRNAMMP-10, migration and tube formation were significantly inhib-
ited. Akt/mTOR/S6 signalling was found to be involved in upregulating MMP-1 and MMP-10 expression, and the
sequential blockade of steps in the pathways effectively prevented Tp47-induced angiogenesis.
Conclusion The results reveal the underlying mechanism of angiogenesis promoted by Tp47, namely, upregulating
MMP-1 and MMP-10 expression to disrupt the MMP/TIMP balance through the Akt/mTOR/S6 pathway. These findings
contribute to our understanding of the pathophysiology of syphilis.
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Introduction
Syphilis is a sexually transmitted disease caused by Treponema
pallidum subsp. pallidum. The prevention and treatment of
syphilis are important public health problems worldwide.1,2
Typical histologic features of the first stage of the disease (pri-
mary syphilis) consist of proliferating small vessels surrounded
by T. pallidum, plasma cells, lymphocytes and macrophages.3,4
At the second stage (secondary syphilis), T. pallidum causes a
plethora of clinical manifestations characterized by vascular
inflammation and increased angiogenesis.5,6 In tertiary syphilis,
unresolved angiogenesis is the underlying mechanism responsi-
ble for skeletal changes.7 Overall, angiogenesis appears to play a
pivotal role in syphilis pathogenesis, as with other diseases (e.g.
cancer, infections and immune disorders).8†These authors contributed equally to this work.
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Similar to most biological processes, angiogenesis is a com-
plex multistep process. Matrix metalloproteinase (MMP)
activity is one of the earliest and most sustained events in
the course of the angiogenic program.9 MMP activity is regu-
lated primarily by tissue inhibitor of metalloproteinase
(TIMP), the main role of which is to inhibit the activity of
MMP. To date, four members of this family have been iden-
tified: TIMP-1, TIMP-2, TIMP-3 and TIMP-4. The balance of
MMP and TIMP is important for regulating a wide range of
angiogenesis processes, including extracellular matrix (ECM)
degradation as well as cell growth and migration,10 and this
balance can be disrupted via activation of endothelial cells to
modulate MMP/TIMP expression.11,12
However, little is known about whether the balance of MMP
and TIMP is disturbed in syphilis-associated angiogenesis, and
the related mechanisms remain unclear. Previous studies have
found that the T. pallidum antigen Tp47, a major integral mem-
brane immunogen of this spirochaete,13,14 is able to activate
endothelial cells to express inflammatory factors, playing an
important role in the T. pallidum-induced inflammatory
response.15,16 Therefore, we propose that Tp47 disturbs the
MMP/TIMP balance by inducing MMP or suppressing TIMP
expression in endothelial cells and that this MMP/TIMP imbal-
ance induces syphilis-associated angiogenesis. In this study, we
evaluated the influence of Tp47 on the proliferation, migration
and tube formation of endothelial cells and on angiogenesis in
zebrafish embryos. Furthermore, we investigated the altered
MMP/TIMP balance and the signalling pathways involved in this
process.
Materials and methods
Cell culture
Human umbilical vein endothelial cells (HUVECs; ScienCell
Research Laboratories, Carlsbad, CA, USA) were incubated with
endothelial cell medium containing 5% fetal bovine serum
(FBS) and 1% endothelial cell growth supplement (ScienCell
Research Laboratories) for the experiment described below.
Preparation of the recombinant T. pallidum Tp47 protein
removed endotoxin
Endotoxin was removed from the recombinant T. pallidum
Tp47 protein (Boson Biotech Co., Ltd., Xiamen, China) as
described previously.17
HUVEC proliferation assay
Human umbilical vein endothelial cells were seeded into a 96-
well plate (1 9 104 cells/well) for 12 h and stimulated with dif-
ferent concentrations of Tp47 (0, 1, 5, 10, 25 or 50 lg/mL) for
24 h. HUVEC proliferation was then determined using Cell
Counting Kit-8 (CCK-8; Dojindo, Kumamoto, Japan) according
to the manufacturer’s protocols.
Transwell chamber migration assay
Human umbilical vein endothelial cells (4 9 104/mL, 200 lL)
were seeded in the upper Transwell chamber (6.5 mm; 8 mmol/
L pore; Corning Costar, Cambridge, MA, USA) with different
concentrations of Tp47 (0, 1, 5, 10, 25 or 50 lg/mL); the bottom
chamber contained 700 lL of endothelial cell medium with 5%
FBS. For the inhibition assay, the cells were pretreated with
20 lmol/L LY294002 (an Akt inhibitor; Sigma-Aldrich, St.
Louis, MO, USA) or 30 nmol/L rapamycin (an mTOR inhibitor;
Sigma-Aldrich) for 1 h and then stimulated with 50 lg/mL
Tp47 for 12 h. A migration assay was performed as described
previously.18
In vitro wound-healing migration assay
The wound-healing assay was performed using ibidi Culture-
Insert (ibidi GmbH, Munich, Germany) according to the manu-
facturer’s protocol. For inhibition assays, cells were pretreated
with LY294002 (20 lmol/L) or rapamycin (30 nmol/L) for 1 h
and then stimulated with 50 lg/mL Tp47. Per cent closure was
calculated according to the following equation: wound-healing
area (%) = [(open area at 0 h –open area at 12 h)/open area at
0 h] 9 100%.
In vitro endothelial tube-formation assay
In vitro endothelial tube formation was assessed by observing the
formation of capillary-like structures by HUVECs on Matrigel
(BD Biosciences, San Jose, CA, USA). The cells were incubated
with different concentrations of Tp47 (0, 1, 5, 10, 25 or 50 lg/
mL) for 18 h. For inhibition assays, the cells were pretreated
with LY294002 (1, 10, 20 lmol/L) or rapamycin (10, 20,
30 nmol/L) for 1 h and then stimulated with 50 lg/mL Tp47
for 18 h. The number of branch junction points and the branch
lengths were determined using a method described previously.19
Zebrafish subintestinal vessel angiogenesis assay
A zebrafish subintestinal vessel angiogenesis assay was performed
according to a previously reported method.20 Zebrafish embryos
were injected with different concentrations of Tp47 (22, 44 or
88 ng/fish) or PBS (control group). After treatment for 24 h, the
area and sprout number of subintestinal vessels were calculated
to evaluate the effect of Tp47 on angiogenesis. All experiments
conformed to the Association for Assessment and Accreditation
of Laboratory Animal Care guidelines on the ethical use of
animals.
MMP antibody array
The expression profile of MMP-related proteins was analysed
using a RayBio Matrix Metalloproteinase Antibody Array (AAH-
MMP-1; RayBiotech Inc., Norcross, GA, USA). HUVECs were
stimulated with PBS (control) or 50 lg/mL Tp47 for 24 h. The
cell culture medium was added to the antibody array membranes
following the manufacturer’s instructions.
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Analysis of MMP-1, MMP-10, TIMP-1 and TIMP-2 mRNA
expression
The mRNA expression levels of MMP-1, MMP-10, TIMP-1 and
TIMP-2 were assessed by RT-PCR as described previously.21 The
primers used in these real-time RT-PCR analyses are listed in
Table 1.
Analysis of MMP-1, MMP-10, TIMP-1 and TIMP-2 protein
expression
Cell culture supernatants were collected and used to detect
MMP-1, MMP-10, TIMP-1 and TIMP-2 levels with commercial
ELISA kits according to the manufacturers’ protocols. MMP-1
and TIMP-1 ELISA kits were purchased from RayBiotech Inc.
MMP-10 and TIMP-2 ELISA kits were purchased from NEO-
BIOSCIENCE Biotechnology Co., Ltd. (Beijing, China).
MMP-1 and MMP-10 activity fluorescence assay
The activity of MMP-1 and MMP-10 was quantified using
Human Active MMP-1 Fluorescent Assay (R&D Systems, Inc.,
Minneapolis, MN, USA) and a SensoLyteTM 520 MMP-10 Assay
Kit *Fluorimetric* (AnaSpec, Inc., San Jose, CA, USA). Briefly,
cells were incubated with different concentrations of Tp47 for
24 h, and the culture supernatants were collected and assayed
for the activity of MMP-1 and MMP-10 according to the manu-
facturer’s instructions. For inhibition assays, cells were pre-
treated with LY294002 (20 lmol/L) or rapamycin (30 nmol/L)
for 1 h before 50 lg/mL Tp47 stimulation.
siRNA transfection assay in HUVECs
MMP-1 and MMP-10 gene expression was silenced via siRNA
transfection. HUVECs were seeded in six-well plates; when the
cells had grown to 40% confluence, siRNA targeting MMP-1
(100 nmol/L) or MMP-10 (100 nmol/L), riboFECTTM buffer
and riboFECTTM CP reagent (Guangzhou RiboBio Co., Ltd.
Guangzhou, Guangdong Province, China) were mixed with cul-
ture medium according to the manufacturer’s recommenda-
tions. The cocktail was added to the plate and incubated with
the cells for 24 h. The HUVECs were then stimulated with
50 lg/mL Tp47, and cell proliferation, migration, wound-heal-
ing and tube-formation assays were performed.
Akt/mTOR/S6 signalling pathway activation assay
Human umbilical vein endothelial cells were stimulated with
50 lg/mL Tp47 for various periods of time. The cell lysates were
collected, and the levels of phosphorylated and total mTOR, Akt
and S6 proteins were detected by Western blotting as described
previously.22,23 For inhibition assays, HUVECs were preincu-
bated with 20 lmol/L LY294002 or 30 nmol/L rapamycin for
1 h and then stimulated with 50 lg/mL Tp47 for 30 min. The
Akt/mTOR/S6 signalling pathway antibodies used were pur-
chased from Cell Signaling Technology (Danvers, MA, USA). In
addition, cells were stimulated as described above for 24 h to
detect the mRNA and protein expression levels of MMP-1,
MMP-10, TIMP-1 and TIMP-2 by RT-PCR and ELISA, respec-
tively.
Statistical analysis
All statistical analyses were performed using SPSS 22.0 for Win-
dows (SPSS Inc., Chicago, IL, USA). The results of the present
study are expressed as means  standard deviations (SDs).
One-way ANOVA was employed to compare values among multi-
ple groups. The statistical significance of differences between the
control and experimental groups in the MMP array was deter-
mined using a paired t-test. A 2-tailed P value of <0.05 was con-
sidered statistically significant.
Results
Effects of Tp47 on the proliferation, migration and tube
formation of HUVECs in vitro and angiogenesis in vivo
We first detected the effects of Tp47 on HUVEC proliferation by
incubating the cells with different concentrations of Tp47 to
analyse effects on proliferation at 12 and 24 h. As shown in
Fig. 1a,b, the proliferation of HUVECs stimulated by Tp47 was
significantly increased in a dose-dependent manner.
Along with increased proliferation, we determined the influ-
ence of Tp47 on HUVEC motility by performing a Transwell
assay. The number of migrated cells was notably increased and
showed a dose-dependent pattern (Fig. 1c). In addition, wound-
healing assays showed significant promotion of the wound-heal-
ing area in a concentration-dependent manner (Fig. 1d).
The role of Tp47 in HUVEC tube formation was explored
using a Matrigel model in vitro. HUVECs formed a complete
tube network within 18 h of postseeding (Fig. 1e), and tube for-
mation was observed in all groups. The number of branch junc-
tion points and the branch lengths were clearly increased, with a
concentration-dependent pattern.
To further confirm whether Tp47 has a pro-angiogenic effect
in vivo, we observed rapid angiogenesis effects of Tp47 in zebra-
fish embryos. As shown in Fig. 1f–h, the area of subintestinal
Table 1 Primers used for RT-PCR analysis
Gene Oligonucleotide primer sequences (50-30)
MMP-1 Forward TGTCACACCTCTGACATTCACCAA
Reverse AAATGAGCATCCCCTCCAATACCT
MMP-10 Forward GGCTCTTTCACTCAGCCAAC
Reverse TCCCGAAGGAACAGATTTTG
TIMP-1 Forward TGCGGATACTTCCACAGGTC
Reverse GCATTCCTCACAGCCAACAG
TIMP-2 Forward AAGAGCCTGAACCACAGGTA
Reverse GAGCCGTCACTTCTCTTGAT
GADPH Forward GAAGGTGAAGGTCGGAGTC
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Figure 1 The effect of Tp47 on HUVEC proliferation, migration and angiogenesis in vitro. (a) HUVEC proliferation at 12 h, (b) HUVEC pro-
liferation at 24 h, (c and d) the migration ability of HUVECs based on Transwell and wound-healing assays (1009). (e) The angiogenic abil-
ity of HUVECs based on the tube-formation assay (1009). (f) The subintestinal vessels of zebrafish embryos, as determined by
fluorescence microscopy (1009). (g) The total area of subintestinal vessels (in pixels). (h) The sprout number of subintestinal vessels.
Values are the means  SDs of triplicate samples and are representative of three independent experiments. One-way ANOVA was used to
compare values among multiple groups (*P < 0.05, **P < 0.01, ***P < 0.001).
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Figure 2 Tp47-induced expression of MMP and TIMP in HUVECs. (a and b) The expression profile of MMP and TIMP based on Human
MMP Array Kit. (c and d) mRNA expression of MMP-1 and MMP-10. (e and f) mRNA expression of TIMP-1 and TIMP-2. (g and h) Total
protein expression of MMP-1 and MMP-10. (i and j) Levels of active MMP-1 and MMP-10 proteins. (k and l) Protein expression of TIMP-1
and TIMP-2. Values are the means  SDs of triplicate samples and are representative of three independent experiments. The statistical
significance of differences between the control and experimental data for the matrix metalloproteinase protein array was analysed using a
paired t-test. One-way ANOVA was used to compare values among multiple groups (*P < 0.05, **P < 0.01, ***P < 0.001). MMP-1, matrix
metalloproteinase-1; MMP-10, matrix metalloproteinase-10; NEG, negative; NS, not significant; POS, positive; TIMP-1, tissue inhibitor of
metalloproteinases-1; TIMP-2, tissue inhibitor of metalloproteinases-2.
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vessels was clearly increased in the 44 and 88 ng/fish groups, and
the sprout number was significantly higher in these groups than
in the PBS group.
Effects of Tp47 on MMP and TIMP expression in HUVECs
We also conducted an MMP antibody array assay to analyse
the ability of Tp47 to modulate expression of MMP and
TIMP in HUVECs (Fig. 2a). Compared with the control,
Tp47 significantly stimulated secretion of MMP-1 and
MMP-10, though expression of TIMP-1 and TIMP-2 did not
differ significantly between groups (Fig. 2b). Moreover,
expression of MMP-2, MMP-3, MMP-8, MMP-9, MMP-13
and TIMP-4 was not detected.
In addition, we further clarified the effects of Tp47 on
MMP-1, MMP-10, TIMP-1 and TIMP-2 expression in
HUVECs at both transcriptional and translational levels. The
results showed that Tp47 markedly elevated MMP-1 and
MMP-10 mRNA expression in a concentration-dependent
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Figure 3 The effect of MMP-1 and MMP-10 on Tp47-induced angiogenesis. (a and b) mRNA expression of MMP-1 and MMP-10. (c and
d) Total protein expression of MMP-1 and MMP-10. (e and f) Levels of active MMP-1 and MMP-10 proteins. (g–j) Protein expression of
TIMP-1 and TIMP-2. (k) The proliferation ability of HUVECs based on the CCK-8 assay. (l and m) The migration ability of HUVECs based
on Transwell and wound-healing assays (1009). (n) The angiogenesis ability of HUVECs based on tube-formation assay (1009). Values
are the means  SDs of triplicate samples and are representative of three independent experiments. One-way ANOVA was used to com-
pare values among multiple groups (***P < 0.001). MMP-1, matrix metalloproteinase-1; MMP-10, matrix metalloproteinase-10; NS, not
significant; TIMP-1, tissue inhibitor of metalloproteinases-1; TIMP-2, tissue inhibitor of metalloproteinases-2.
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manner (Fig. 2c,d). Specifically, levels of MMP-1 and MMP-
10 mRNA were significantly increased by 10 lg/mL Tp47
and reached a maximal response with 50 lg/mL Tp47. In
contrast, no significant effects between the groups were
found for mRNA expression of TIMP-1 and TIMP-2
(Fig. 2e,f). MMP-1 total protein was significantly increased
by Tp47 in a concentration-dependent manner (Fig. 2g,h).
Furthermore, active MMP-1 and MMP-10 were also clearly
elevated by Tp47 in a concentration-dependent manner
(Fig. 2i,j). At the same time, expression of TIMP-1 and
TIMP-2 proteins was not significantly different between the
groups (Fig. 2k,l).
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Effects of Tp47-induced MMP expression on HUVEC
proliferation, migration and tube formation
The above results show that Tp47 induced the proliferation,
migration and tube formation of HUVECs and increased
expression levels of MMP-1 and MMP-10. Thus, the role of
MMP in Tp47-induced migration and tube formation was
analysed further by transfecting HUVECs with siRNA targeting
MMP-1 and MMP-10. First, the gene expression of MMP-1
and MMP-10 and total protein levels elevated by Tp47 were
inhibited by siRNAMMP-1 or siRNAMMP-10 (Fig. 3a–d). In
addition, levels of the active forms of MMP-1 and MMP-10
induced by Tp47 also decreased (Fig. 3e,f). However, TIMP-1
and TIMP-2 protein expression showed no significant differ-
ence between the groups (Fig. 3g–j). These results indicate that
MMP expression was significantly inhibited. Furthermore, the
proliferation induced by Tp47 was significantly inhibited by
siRNAMMP-1 or siRNAMMP-10 (Fig. 3k), and Transwell
migration and wound-healing assay showed that the Tp47-in-
duced migration of HUVECs was considerably weakened by
siRNAMMP-1 or siRNAMMP-10 (Fig. 3l,m). In addition,
Tp47-induced tube formation by HUVECs was significantly
inhibited by siRNAMMP-1 or siRNAMMP-10, with the num-
ber of branch junction points and branch lengths clearly
decreasing (Fig. 3n).
Effects of Akt/mTOR/S6 signalling on MMP and TIMP
expression in HUVECs
To explore the mechanism by which Tp47 induces MMP secre-
tion, we first evaluated the role of the Akt/mTOR/S6 pathways
by Western blot analysis to detect the total and phosphorylated
protein levels of Akt, mTOR and S6 after stimulation with
50 lg/mL Tp47 for various durations. As shown in Fig. 4a–d,
phosphorylation of Akt was stimulated by Tp47 in a time-de-
pendent manner. However, LY294002 significantly reduced
p-Akt, p-mTOR and p-S6 levels in a concentration-dependent
manner (Fig. 5a–d) and decreased the mRNA and total protein
expression of MMP-1 and MMP-10, also in a concentration-
dependent manner (Fig. 5e–h). Active forms of MMP-1 and
MMP-10 were also reduced in a concentration-dependent man-
ner (Fig. 5i,j), though the mRNA and protein levels of TIMP-1
and TIMP-2 were not affected (Fig. 5k–n). Similarly, rapamycin
clearly inhibited phosphorylation of mTOR, Akt and S6 in a
concentration-dependent manner (Fig. 6a–d) and decreased
both the mRNA and total protein expression of MMP-1 and
MMP-10 stimulated by Tp47 (Fig. 6e–h). In addition, levels of
the active forms of MMP-1 and MMP-10 were reduced in a con-
centration-dependent manner (Fig. 6i,j). Conversely, the mRNA
and protein levels of TIMP-1 and TIMP-2 were not significantly
altered (Fig. 6k–n).
Further experiments were then designed using Akt and
mTOR inhibitors to elucidate whether the Akt/mTOR/S6 sig-
nalling pathways are involved in Tp47-induced HUVEC
proliferation, migration and capillary tube formation. Tp47-
induced proliferation was obviously inhibited by preincuba-
tion with LY294002 or rapamycin (Fig. 7a), and the cell
migration and wound-healing area promoted by Tp47 were
significantly reduced by LY294002 or rapamycin (Fig. 7b,c).
The number of branch junction points and the branch
lengths induced by Tp47 were also significantly attenuated by
treatment with these inhibitors (Fig. 7d).
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Figure 4 Tp47-induced activation of Akt/mTOR/S6 signalling in
HUVECs. (a) Time course of Akt/mTOR/S6 pathway activation, as
determined by Western blot analysis. (b and c) Summary of results
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Figure 6 Effects of the mTOR inhibitor rapamycin on phosphorylation of Akt, mTOR and S6 and expression of MMP-1 and MMP-10. (a)
Phosphorylated and total protein levels of Akt, mTOR and S6. (b–d) Densitometric analysis of Western blots. (e–h) mRNA and total protein
expression of MMP-1 and MMP-10. (i and j) Levels of active MMP-1 and MMP-10 proteins. (k–n) mRNA and protein expression of TIMP-
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Discussion
Angiogenesis plays a crucial role in diseases, including tumours,
immune disorders, and infectious and inflammatory diseases.8
Infection-associated angiogenesis has been described in a variety
of pathogen infections, and this process is beneficial for patho-
gen survival.24 It is known that angiogenesis is a crucial event in
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the pathogenesis of syphilis.3–7,25 Those studies have shown that
angiogenesis is one of the major pathological features of dermal
lesions in primary and secondary syphilis and that it plays a role
in the skeletal changes that occur in tertiary syphilis. Chemoki-
nes (such as IL-8) may play a role in this process. However, little
about the details of the underlying mechanisms is known. Thus,
the mechanisms by which T. pallidum induces host angiogenesis
are important and may provide a novel potential therapeutic
strategy in syphilis. In our study, we found that Tp47 was able to
induce the proliferation, migration and tube formation of
HUVECs in vitro. In addition, Tp47 stimulated angiogenesis in
zebrafish embryos in vivo. These results suggest that Tp47 might
be crucial for triggering angiogenesis responses during T. pal-
lidum infection.
Matrix metalloproteinases are tightly controlled by mole-
cules regulating their expression and by specific inhibitors of
MMPs called TIMPs. An imbalance between MMPs and
TIMPs is associated with a wide range of physiological and
pathological events, including angiogenesis, invasion and
metastasis.26 We detected MMP expression and found that
levels of MMP-1 and MMP-10 were markedly increased in
HUVECs stimulated with Tp47. We further found that the
activity of MMP-1 and MMP-10 was notably elevated. MMP-
1 is a collagenase that degrades fibrillar collagens, and this
activity has been implicated in various biological processes,
including tumour invasion, angiogenesis and periodontal dis-
ease.27,28 MMP-10 is a 56-kDa member of the stromelysin
subset of MMPs and plays a crucial role in vascular remod-
elling,29 cancer invasion and metastasis30 and immunity.31
However, few studies have focused on the role of MMP-1
and MMP-10 in infection-associated angiogenesis. In this
study, we further confirmed that migration and tube forma-
tion were significantly inhibited after siRNAMMP-1 and siR-
NAMMP-10 transfection, indicating that upregulation of
MMP-1 and MMP-10 is required for Tp47-induced angiogen-
esis. Notably, the results of previous studies have revealed
that MMP-2 and MMP-9 play a critical role in angiogenesis
during tumour development and progression.9 However,
expression of MMP-2 and MMP-9 was not detected in our
study.
By inhibiting MMP activity, TIMP plays an important role
in regulating a wide range of pathological processes, including
angiogenesis and cancer invasion.26 Previous studies have
shown that angiogenesis can be stimulated by visfatin
through induction of MMP expression and inhibition of
TIMP-1/2 expression.32 Moreover, cryptotanshinone can sup-
press angiogenesis in colon cancer by inhibiting expression of
both MMP-2 and MMP-9 and promoting that of TIMP-1
and TIMP-2.33 Platelet microvesicles promote angiogenesis by
upregulating MMP-2 and MMP-9 expression, with no signifi-
cant influence on expression of TIMP-118. These findings
indicate that an imbalance between MMP/TIMP plays an
important role in the process of angiogenesis. Accordingly,
we also investigated TIMP-1 and TIMP-2 mRNA and protein
expression and found no significant changes, indicating that
expression of these molecules is not modulated by Tp47.
Together with previous findings, our results suggest that
Tp47 causes an imbalance of MMP/TIMP by enhancing
MMP-1 and MMP-10 expression and activity, ultimately
inducing angiogenesis.
By inducing secretion of pro-angiogenic factors, Akt/mTOR
signalling plays an important role in angiogenesis.34 The
pathways are also critical for regulating the migration and
invasion of cancer cells by modulating expression of MMPs
and TIMPs.33,35 In the present study, LY294002 and rapamy-
cin clearly inhibited Tp47-induced phosphorylation of Akt/
mTOR/S6 and attenuated MMP-1 and MMP-10 expression
and activity in a concentration-dependent manner. However,
expression of TIMP-1 and TIMP-2 did not change signifi-
cantly. Furthermore, Tp47-induced migration and tube for-
mation were inhibited by LY294002 and rapamycin. These
results suggest that Tp47-stimulated phosphorylation of Akt/
mTOR/S6 is required for MMP-1 and MMP-10 upregulation,
which disturbs the MMP/TIMP balance and ultimately
induces angiogenesis in HUVECs.
Limitations
Several potential limitations should be noted. First, only certain
MMPs were detected by the MMP antibody array in our study.
The role of other MMPs, such as membrane-type MMPs, in
angiogenesis requires further research. Second, angiogenesis is a
multistep process that includes multicellular interactions
between HUVECs and other cells, and knowledge of the means
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Figure 8 A schematic diagram illustrating the proposed mecha-
nism for the imbalance of MMP/TIMP and the related signalling
pathways involved in Tp47-induced HUVEC angiogenesis.
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by which Tp47 influences cell–cell interactions in angiogenesis is
needed. Third, the role of pro-angiogenic factors, such as growth
factors, chemokines and interleukins, in this process requires
further exploration.
Conclusion
In summary, the present study provides evidence that TP47
causes an imbalance of MMP/TIMP by increasing the expression
and activity of MMP-1 and MMP-10 and prompts angiogenesis
through Akt/mTOR/S6 signalling in HUVECs (Fig. 8). Details
about the role of Tp47 in the MMP/TIMP balance and the rele-
vant mechanisms represent another step towards understanding
syphilis pathophysiology.
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